SCHEMBL17058558

SCHEMBL17058558

CC1(COc2c(N3CCN([S+]([O-])Cc4ccc5c(c4)OC(CO)N5)CC3)cnn(-c3cc(F)cc(F)c3)c2=O)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17058559 0.82 POLB (0.33) —
SCHEMBL17057972 0.81 POLB (0.33) —
SCHEMBL17058268 0.79 — —
SCHEMBL17058018 0.79 — —
SCHEMBL17058289 0.78 NPBWR1 (0.34) —
SCHEMBL17058529 0.78 SMN1; SMN2 (0.34) —
SCHEMBL17057853 0.78 SMN1; SMN2 (0.35) —
SCHEMBL17058032 0.77 — —
SCHEMBL17057873 0.77 UTRN (0.32) —
SCHEMBL17058218 0.77 ALDH1A1 (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2137179-B1 PYRIDAZINONE DERIVATIVES USEFUL AS GLUCAN SYNTHASE INHIBITORS MERCK SHARP & DOHME (US) 2015-09-02 — — EP disclosed
Send feedback